RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+6.05%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$2.34B
AUM Growth
+$2.34B
(-6.9%)
Cap. Flow
-$241M
Cap. Flow
% of AUM
-10.29%
Top 10 Holdings %
Top 10 Hldgs %
43.52%
Holding
80
New
8
Increased
13
Reduced
27
Closed
17
Top Buys
| 1 |
Viatris
VTRS
|
$119M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$107M |
| 3 |
Magnite
MGNI
|
$30.2M |
| 4 |
NRG Energy
NRG
|
$25.7M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
$13.2M |
Top Sells
| 1 |
Scorpio Tankers
STNG
|
$64.8M |
| 2 |
Cameco
CCJ
|
$62.5M |
| 3 |
First Citizens BancShares
FCNCA
|
$51.6M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$37.6M |
| 5 |
Cimpress
CMPR
|
$29.1M |
Sector Composition
| 1 | Healthcare | 33.25% |
| 2 | Energy | 14.35% |
| 3 | Industrials | 13.83% |
| 4 | Financials | 10.77% |
| 5 | Utilities | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTVE
26
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $36.5M | 1.56% | 4,815,783 | – | – |
|
27
Koppers
KOP
$571M
| $36.3M | 1.55% | 1,065,441 -45,556 | -4% | -$1.55M |
|
28
Roivant Sciences
ROIV
$8.15B
| $35.6M | 1.52% | 3,536,438 -2,063,562 | -37% | -$20.8M |
|
29
AdaptHealth
AHCO
$1.28B
| $35M | 1.5% | 2,879,139 -434,951 | -13% | -$5.29M |
|
|
HOLI
30
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $34.1M | 1.46% | 1,941,237 -35,372 | -2% | -$622K |
|
31
TransAlta
TAC
$3.65B
| $32.1M | 1.37% | 3,426,490 -2,359,073 | -41% | -$22.1M |
|
|
32
Magnite
MGNI
$3.7B
| $30.2M | 1.29% | +2,214,022 | New | +$30.2M |
|
|
33
NRG Energy
NRG
$28.2B
| $25.7M | 1.1% | +688,027 | New | +$25.7M |
|
34
Clear Channel Outdoor Holdings
CCO
$616M
| $23.8M | 1.02% | 17,391,427 | – | – |
|
35
Zymeworks
ZYME
$1.12B
| $20.4M | 0.87% | 2,357,577 -497,155 | -17% | -$4.3M |
|
36
Sutro Biopharma
STRO
$72.7M
| $18.8M | 0.81% | 4,048,744 -311,743 | -7% | -$1.45M |
|
37
ARS Pharmaceuticals
SPRY
$1.15B
| $18.8M | 0.8% | 2,799,203 -681,509 | -20% | -$4.57M |
|
38
Ovid Therapeutics
OVID
$91M
| $17.9M | 0.76% | 5,445,910 -1,555,214 | -22% | -$5.1M |
|
39
RadNet
RDNT
$5.52B
| $16.8M | 0.72% | 516,076 +110,657 | +27% | +$3.61M |
|
|
MREO
40
Mereo BioPharma
MREO
$272M
| $15.3M | 0.66% | 11,616,120 +1,250,000 | +12% | +$1.65M |
|
41
Heron Therapeutics
HRTX
$207M
| $13.6M | 0.58% | 11,750,000 | – | – |
|
42
Trevi Therapeutics
TRVI
$883M
| $13.6M | 0.58% | 5,684,420 | – | – |
|
43
Telesat
TSAT
$307M
| $11.9M | 0.51% | 1,267,065 -142,935 | -10% | -$1.35M |
|
44
FTAI Infrastructure
FIP
$552M
| $11.8M | 0.5% | 3,193,530 | – | – |
|
45
DigitalBridge
DBRG
$2.08B
| $11.7M | 0.5% | +795,516 | New | +$11.7M |
|
46
Digimarc
DMRC
$188M
| $11.1M | 0.47% | 375,353 -830,365 | -69% | -$24.4M |
|
47
Magnachip Semiconductor
MX
$113M
| $10.8M | 0.46% | 967,867 -715,595 | -43% | -$8M |
|
48
PLAYSTUDIOS Inc
MYPS
$121M
| $9.63M | 0.41% | 1,961,184 | – | – |
|
49
scPharmaceuticals
SCPH
$295M
| $8.27M | 0.35% | +811,517 | New | +$8.27M |
|
50
Amneal Pharmaceuticals
AMRX
$3B
| $8.06M | 0.34% | +2,601,379 | New | +$8.06M |
|